Bioresponsive materials in response to biological signals or pathological abnormalities are promising for the development of precision medications. Researchers have focused on the innovations in the areas of materials chemistry, pharmaceutical science, and micro-and nanofabrication to develop bioresponsive systems for targeting drug delivery, controlled drug release, and so on. These designs have greatly enhanced the efficacy of the existing drugs while decreasing their side effects. Given the significant progress of this field, the investigations of bioresponsive drug delivery or release systems should be enhanced to facilitate the future translation of nanomaterials.
The goal of this Research Topic is to publish research articles in full length, short communications, review articles, and opinions covering the latest studies, progress, and challenges on bioresponsive nanomaterials for drug delivery or controlled release.
The main scope of the Research Topic encompasses new concepts in design, synthesis, preparation as well as evaluation of bioresponsive nanomaterials in response to physiological/pathological signals in vivo for drug delivery or controlled drug release. We welcome submissions in the following themes, but not limited to:
(1) Design, synthesis, preparation, characterization, and evaluation of bioresponsive nanomaterials in response to physiological/pathological signals for delivery of active pharmaceutical ingredients including chemo-drugs, imaging agents, immune-related drugs, photothermal agents, antimicrobial agents, cardiovascular agents, and so on.
(2) Development and evaluation of bioresponsive depot for controlling drug release at the local sites, such as bioresponsive hydrogel, micro-needles, or the composite systems with nanoparticles.
(3) Investigation of interaction between bioresponsive nanomaterials and the payloads.
Bioresponsive materials in response to biological signals or pathological abnormalities are promising for the development of precision medications. Researchers have focused on the innovations in the areas of materials chemistry, pharmaceutical science, and micro-and nanofabrication to develop bioresponsive systems for targeting drug delivery, controlled drug release, and so on. These designs have greatly enhanced the efficacy of the existing drugs while decreasing their side effects. Given the significant progress of this field, the investigations of bioresponsive drug delivery or release systems should be enhanced to facilitate the future translation of nanomaterials.
The goal of this Research Topic is to publish research articles in full length, short communications, review articles, and opinions covering the latest studies, progress, and challenges on bioresponsive nanomaterials for drug delivery or controlled release.
The main scope of the Research Topic encompasses new concepts in design, synthesis, preparation as well as evaluation of bioresponsive nanomaterials in response to physiological/pathological signals in vivo for drug delivery or controlled drug release. We welcome submissions in the following themes, but not limited to:
(1) Design, synthesis, preparation, characterization, and evaluation of bioresponsive nanomaterials in response to physiological/pathological signals for delivery of active pharmaceutical ingredients including chemo-drugs, imaging agents, immune-related drugs, photothermal agents, antimicrobial agents, cardiovascular agents, and so on.
(2) Development and evaluation of bioresponsive depot for controlling drug release at the local sites, such as bioresponsive hydrogel, micro-needles, or the composite systems with nanoparticles.
(3) Investigation of interaction between bioresponsive nanomaterials and the payloads.
